Exhaled nitric oxide predicts airway hyper-responsiveness to hypertonic saline in children that wheeze

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 60, Issue 12, 2005, Pages 1499-1504

  De Meer, G ^a,b   Van Amsterdam, J G C ^c   Janssen, N A H ^a   Meijer, E ^a   Steerenberg, P A ^c   Brunekreef, B ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

Airway hyper responsiveness; Exhaled nitric oxide; Predictive values; Screening

Indexed keywords

NITRIC OXIDE; SODIUM CHLORIDE;

ADOLESCENT; ARTICLE; ATOPY; BRONCHUS HYPERREACTIVITY; CALCULATION; CONTROLLED STUDY; EXHALATION; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; QUESTIONNAIRE; RECEIVER OPERATING CHARACTERISTIC; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; SYMPTOMATOLOGY; WHEEZING;

ADOLESCENT; BRONCHIAL HYPERREACTIVITY; CHILD; EXHALATION; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; NITRIC OXIDE; PREDICTIVE VALUE OF TESTS; RESPIRATORY SOUNDS; SALINE SOLUTION, HYPERTONIC;

EID: 27844452449     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2005.00930.x     Document Type: Article

References (32)

1. Burney PG, Luczynska C, Chinn S, Jarvis D. The European community respiratory health survey. Eur Respir J 1994;7:954-960.
2. Asher MI, Keil U, Anderson HR, Beasley R, Crane J, Martinez F et al. International study of asthma and allergies in childhood (ISAAC): rationale and methods. Eur Respir J 1995;8:483-491.
3. Gronke L, Kanniess F, Holz O, Jorres RA, Magnussen H. The relationship between airway hyper-responsiveness, markers of inflammation and lung function depends on the duration of the asthmatic disease. Clin Exp Allergy 2002;32:57-63.
4. Jatakanon A, Kharitonov S, Lim S, Barnes PJ. Effect of differing doses of inhaled budesonide on markers of airway inflammation in patients with mild asthma. Thorax 1999;54:108-114.
5. Mattes J, Storm van's Gravesande K, Reining U, Alving K, Ihorst G, Henschen M et al. NO in exhaled air is correlated with markers of eosinophilic airway inflammation in corticosteroid-dependent childhood asthma. Eur Respir J 1999;13:1391-1395.
6. Piacentini GL, Bodini A, Costella S, Vicentini L, Mazzi P, Sperandio S et al. Exhaled nitric oxide and sputum eosinophil markers of inflammation in asthmatic children. Eur Respir J 1999;13:1386-1390.
7. Jones SL, Kittelson J, Cowan JO, Flannery EM, Hancox RJ, McLachlan CR et al. The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control. Am J Respir Crit Care Med 2001;164:738-743.
8. van den Toorn LM, Overbeek SE, de Jongste JC, Leman K, Hoogsteden HC, Prins JB. Airway inflammation is present during clinical remission of atopic asthma. Am J Respir Crit Care Med 2001;164:2107-2113.
9. van Rensen EL, Straathof KC, Veselic-Charvat MA, Zwinderman AH, Bel EH, Sterk PJ. Effect of inhaled steroids on airway hyperresponsiveness, sputum eosinophils, and exhaled nitric oxide levels in patients with asthma. Thorax 1999;54:403-408.
10. Ichinose M, Takahashi T, Sugiura H, Endoh N, Miura M, Mashito Y et al. Baseline airway hyperresponsiveness and its reversible component: role of airway inflammation and airway calibre. Eur Respir J 2000;15:248-253.
11. Currie GP, Syme-Grant NJ, McFarlane LC, Carey FA, Lipworth BJ. Effects of low dose fluticasone/salmeterol combination on surrogate inflammatory markers in moderate persistent asthma. Allergy 2003;58:602-607.
12. dal Negro R, Micheletto C, Tognella S, Turco P, Rossetti A, Cantini L. Assessment of inhaled BDP-dose dependency of exhaled nitric oxide and local and serum eosinophilic markers in steroids-naive nonatopic asthmatics. Allergy 2003;58:1018-1022.
13. Mahut B, Delclaux C, Tillie-Leblond I, Gosset P, Delacourt C, Zerah-Lancner F et al. Both inflammation and remodeling influence nitric oxide output in children with refractory asthma. J Allergy Clin Immunol 2004;113:252-256.
14. Ho LP, Wood FT, Robson A, Innes JA, Greening AP. Atopy influences exhaled nitric oxide levels in adult asthmatics. Chest 2000;118:1327-1331.
15. Steerenberg PA, Janssen NA, de Meer G, Fischer PH, Nierkens S, van Loveren H et al. Relationship between exhaled NO, respiratory symptoms, lung function, bronchial hyperresponsiveness, and blood eosinophilia in school children. Thorax 2003;58:242-245.
16. Franklin PJ, Turner SW, le Souef PN, Stick SM. Exhaled nitric oxide and asthma: complex interactions between atopy, airway responsiveness, and symptoms in a community population of children. Thorax 2003;58:1048-1052.
17. de Meer G, Postma DS, Janssen NA, de Jongste JC, Brunekreef B. Bronchial hyper-responsiveness to hypertonic saline and blood eosinophilic markers in 8-13-year-old schoolchildren. Clin Exp Allergy 2004;34:1226-1231.
18. European Respiratory Society. Standardized lung function testing. Eur Respir J 1993;6:5-40.
19. Zapletal A, Paul T, Samanek M. Die Bedeutung heutiger Methoden der Lungfunktionsdiagnostik zur Feststellung einer Obstruktion der Atemwege bei Kindern und Jugendlichen. (Significance of current methods of lung function assessment for establishing airways obstruction in children and adolescents). Z Erkrank Atem-Org 1977;149:525-550.
20. Steerenberg PA, Nierkens S, van Loveren H, van Amsterdam JG. A simple method to sample exhaled NO not contaminated by ambient NO from children and adults in epidemiological studies. Nitric Oxide 2000;4:168-174.
21. van Amsterdam JG, Zanen P, Somer S, van Loveren H, Opperhuizen A, Steerenberg PA. Flow dependency and off-line measurement of exhaled NO in children. Pediatr Allergy Immunol 2003;14:266-271.
22. Jobsis Q, Raatgeep HC, Hop WC, de Jongste JC. Controlled low flow off line sampling of exhaled nitric oxide in children. Thorax 2001;56:285-289.
23. Kharitonov SA, Alving K, Barnes PJ. Exhaled and nasal nitric oxide measurements: recommendations. The European Respiratory Society Task Force. Eur Respir J 1997;10:1683-1693.
24. Recommendations for standardized procedures for the on-line and off-line measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children. Am J Respir Crit Care Med 1999;160:2104-2117.
25. Atkinson AC. A note on the generalized information criterion for choice of a model. Biometrica 1980;67:413-418.
26. Weinstein MC, Fineberg HV. Clinical decision analysis. Philadelphia: WB Saunders, 1980.
27. Berlyne GS, Parameswaran K, Kamada D, Efthimiadis A, Hargreave FE. A comparison of exhaled nitric oxide and induced sputum as markers of airway inflammation. J Allergy Clin Immunol 2000;106:638-644.
28. Little SA, Chalmers GW, Macleod KJ, McSharry C, Thomson NC. Non-invasive markers of airway inflammation as predictors of oral steroid responsiveness in asthma. Thorax 2000;55:232-234.
29. Strunk RC, Szefler SJ, Phillips BR, Zeiger RS, Chinchilli VM, Larsen G et al. Childhood Asthma Research and Education Network of the National Heart, Lung, and Blood Institute. Relationship of exhaled nitric oxide to clinical and inflammatory markers of persistent asthma in children. J Allergy Clin Immunol 2003;112:883-892.
30. Langley SJ, Goldthorpe S, Custovic A, Woodcock A. Relationship among pulmonary function, bronchial reactivity, and exhaled nitric oxide in a large group of asthmatic patients. Ann Allergy Asthma Immunol 2003;91:398-404.
31. Dupont LJ, Demedts MG, Verleden GM. Prospective evaluation of the validity of exhaled nitric oxide for the diagnosis of asthma. Chest 2003;123:751-756.
32. de Meer G, Postma DS, Janssen NA, de Jongste JC, Brunekreef B. BHR to hypertonic saline and blood eosinophilic markers in 8-13 year old school children. Clin Exp Allergy 2004;34:1226-1231.